Riktkurs.nu
EN | SV
CalliditasMid CapCellavision
Stockholm Stock Exchange | Mid Cap
Camurus
+20.53%
Latest
+16.67%
3 months
CarnegieJefferiesNordea MarketsHandelsbankenDNB MarketsDNB

Price Targets

Latest price targets per analyst.

AnalystPrice TargetDateUpside
Carnegie229 SEKMay 13
+20.53%
Jefferies205 SEKApr 4
Nordea Markets231 SEKApr 1
Handelsbanken235 SEKDec -21
DNB Markets275 SEKNov -21
DNB300 SEKJul -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2022